None (Healthy adult)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Signed and dated informed consent form provided, after willingness of participants confirmed 2)Willingness to comply with all study procedures for the period of the study 3)Healthy adult (20 < Age < 30) 4)Persons who have COVID vaccine at least two times and more than 2 weeks have passed after last vaccination 5)Persons who are not currently infected with SARS-CoV2, and if they had been infected, at least 4 weeks have passed since recovery. 6)No underlying acute and/or chronic sickness from respiratory disease and/or gastrointestinal disease at enrolment.
Exclusion criteria
Exclusion criteria: 1)Unable to provide signed and dated informed consent form 2)Unable to comply with all the study procedures 3)Allergic to milk and/or soy (contained within the study products) 4)Regularly using steroid drugs (immune suppressive drugs) 5)Any persons deemed inappropriate as participants by the principal investigators of this study 6)Those currently participating in other clinical trials (participants) or those who are planning to participate in other clinical trials during the study period 7)Women who are pregnant, or intend to get pregnant during the study period, or breastfeeding mothers 8)Cannot stop drinking alcohol for two days before sampling blood
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of test food on biological response of infectious diseases on biological response of blood cells. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. General wellbeing of participants evaluated by questionnaires. 2. Severity of infectious disease like illness 3. Expression of anti-infectious factors | — |
Countries
Asia(except Japan)
Contacts
Kirin Holdings Co., Ltd. Institute of health science